Enric Domingo
机构: Department of Oncology, University of Oxford
每年引用次数
引用次数
引用: 11,690
H-指数: 49
I10-指数 : 63
出版物: 132
Feasibility of whole genome association study to find SNPs predictive of colorectal cancer outcome
Elaine Johnstone , Enric Domingo , Axel Walther , Ian Tomlinson
Clinical Cancer Research 14
2008
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response
Janet Shipley , Clare Turnbull , Joanna L Selfe , Svanhild Nornes
Cancer Research 81 ( 7) 1667 -1680
1
2021
Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA.
Celina Whalley , Karl Payne , Enric Domingo , Andrew Blake
Epigenomes 5 ( 1) 6 -6
2021
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
Dan Rosmarin , Claire Palles , Alistair Pagnamenta , Kulvinder Kaur
Gut 64 ( 1) 111 -120
69
2015
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.
Maryam A Hamdollah Zadeh , Elianna M Amin , Coralie Hoareau-Aveilla , Enric Domingo
Molecular Oncology 9 ( 1) 167 -178
69
2015
POLE (DNA polymerase epsilon, catalytic subunit)
Enric Domingo
Atlas of genetics and cytogenetics in oncology and haematology ( 3)
2019
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN
Andrew D Beggs , Enric Domingo , Megan McGregor , Mikael Presz
Oncotarget 3 ( 11) 1348 -1355
60
2012
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency.
Carla Oliveira , Mafalda Pinto , Alex Duval , Caroline Brennetot
Oncogene 22 ( 57) 9192 -9196
131
2003
BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
Enric Domingo , Renée C Niessen , Carla Oliveira , Pia Alhopuro
Oncogene 24 ( 24) 3995 -3998
153
2005
Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer
Carla Oliveira , Sérgia Velho , Enric Domingo , Ana Preto
Oncogene 24 ( 51) 7630 -7634
46
2005
TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts
John Fielden , Katherine Wiseman , Ignacio Torrecilla , Shudong Li
Nature Communications 11 ( 1) 1274
58
2020
Tumour-infiltrating CD8+ lymphocytes as a prognostic marker in colorectal cancer: A retrospective, pooled analysis of the QUASAR2 and VICTOR trials.
Mark Glaire , Enric Domingo , George Nicholson , Marco Novelli
Journal of Clinical Oncology 36 3515 -3515
2
2018
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
Ningning Li , Roya Babaei-Jadidi , Federica Lorenzi , Bradley Spencer-Dene
Oncogenesis 8 ( 3) 13
34
2019
Replication stress links structural and numerical cancer chromosomal instability
Rebecca A. Burrell , Sarah E. McClelland , David Endesfelder , Petra Groth
Nature 494 ( 7438) 492 -496
785
2013
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Rachel S Kerr , Sharon Love , Eva Segelov , Elaine Johnstone
The Lancet Oncology 17 ( 11) 1543 -1557
142
2016
Is sidedness prognostically important across all stages of colorectal cancer?
David J Kerr , Enric Domingo , Rachel Kerr
The Lancet Oncology 17 ( 11) 1480 -1482
9
2016
'Toxgnostics': an unmet need in cancer medicine
David Church , Rachel Kerr , Enric Domingo , Dan Rosmarin
Nature Reviews Cancer 14 ( 6) 440 -445
23
2014
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Enric Domingo , Luke Freeman-Mills , Emily Rayner , Mark Glaire
The Lancet Gastroenterology & Hepatology 1 ( 3) 207 -216
126
2016
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Enric Domingo , Carme Camps , Pamela J Kaisaki , Marie J Parsons
The Lancet Gastroenterology & Hepatology 3 ( 9) 635 -643
31
2018
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer.
David N Church , Arild Nesbakken , Anita Sveen , Ragnhild A Lothe
ESMO open 5 ( 6)
2020